EU REACH Adds Corrosion Inhibitors Restriction: 3 Borate Substances Banned from March 2027

On 20 May 2026, the European Chemicals Agency (ECHA) confirmed the addition of Entry 79 to Annex XVII of the EU REACH Regulation, banning three borate substances — boric oxide, sodium borate, and calcium borate — in corrosion inhibitors. The restriction takes effect on 1 March 2027. Exporters of corrosion inhibitors from China and other third countries, particularly those supplying industrial water treatment, metalworking fluids, and automotive coolant formulations, must act within the 10-month window to reformulate products and complete new toxicological assessments — or risk losing EU market access.

Event Overview

On 20 May 2026, ECHA officially confirmed that Annex XVII of the REACH Regulation will be amended to include a new Entry 79. Effective 1 March 2027, the use of boric oxide (CAS No. 1303-86-2), sodium borate (CAS No. 1303-96-4), and calcium borate (CAS No. 1303-97-5) in corrosion inhibitors is prohibited. This restriction applies specifically to substances used for corrosion inhibition purposes, not to broader borate applications outside this functional category. The legal text is now finalised and published in the Official Journal of the European Union following the adoption process.

Industries Affected by the Restriction

Direct Exporters of Corrosion Inhibitors

Manufacturers and traders exporting corrosion inhibitors to the EU are directly affected because the restriction targets the final formulated product’s function. If their current formulations contain any of the three listed borates, compliance requires full reformulation — not just labelling or declaration adjustments. Non-compliant products placed on the EU market after 1 March 2027 will be deemed illegal and subject to customs rejection or market withdrawal.

Raw Material Suppliers (Borate Producers & Distributors)

Suppliers of boric oxide, sodium borate, or calcium borate face reduced demand specifically for corrosion inhibition applications in the EU. While these substances remain permitted in other uses (e.g., glass, ceramics, flame retardants), the loss of a defined end-use segment may impact volume forecasts and inventory planning. Their customers’ reformulation timelines will determine near-term order patterns.

Formulators & Contract Manufacturers

Companies blending or customising corrosion inhibitor packages — especially those serving OEMs or industrial clients with EU distribution — must verify all incoming raw materials and finished batches. Even if borates are added at sub-functional levels (e.g., as stabilisers), inclusion in a product marketed or used for corrosion inhibition triggers the ban. Reformulation validation must include updated chemical safety assessments aligned with REACH Article 33 and SVHC communication obligations.

Distributors & Importers in the EU

EU-based importers and distributors bear legal responsibility under REACH for ensuring compliance of imported corrosion inhibitors. They must obtain updated declarations of conformity and safety data sheets (SDS) from suppliers, verify absence of restricted borates via batch-specific analytical testing where necessary, and retain documentation for potential audits by national enforcement authorities.

Key Focus Areas and Recommended Actions for Affected Businesses

Monitor official implementation guidance and enforcement expectations

ECHA and national competent authorities (e.g., UK HSE, Germany BAuA) may issue non-binding guidance on interpretation — for example, whether ‘corrosion inhibitor’ covers multi-functional additives or only single-purpose products. Businesses should track updates via ECHA’s REACH Annex XVII page and national helpdesks, rather than relying solely on trade summaries.

Identify and prioritise high-risk SKUs and supply chain tiers

Map all corrosion inhibitor products exported to the EU against active ingredient lists and supplier SDSs. Flag SKUs containing the three borates — especially those where borates serve a primary or declared corrosion-inhibiting function. Then assess upstream dependencies: e.g., whether a ‘borate-free’ label from a raw material supplier covers all relevant CAS numbers and intended uses.

Distinguish regulatory adoption from operational readiness

The restriction enters into force on 1 March 2027, but commercial lead times for reformulated products — including stability testing, customer approval cycles, and packaging changes — often exceed six months. Businesses should treat the 20 May 2026 confirmation date as the de facto start of the implementation clock, not the 2027 deadline.

Initiate toxicological re-evaluation and documentation updates now

Replacement substances (e.g., molybdates, phosphonates, azoles) require new hazard classification, exposure assessment, and SDS revision under CLP and REACH. Initiating this work early avoids bottlenecks with testing labs and consultants, especially given concurrent demand from multiple affected sectors.

Editorial Perspective / Industry Observation

Observably, this restriction signals a tightening of functional-use controls under REACH — moving beyond substance-by-substance SVHC listings toward application-specific bans. Analysis shows it reflects growing regulatory focus on repeated-dose toxicity and environmental persistence of borates in closed-loop industrial systems, even when human exposure is low. From an industry perspective, it is less a sudden shock and more a formalisation of existing substitution trends already underway among major EU-based formulators since 2023. However, its binding nature and fixed timeline mean it functions as both a compliance milestone and a catalyst for broader supply chain transparency — especially for exporters reliant on legacy borate-based technologies. Continued monitoring is warranted for possible extensions to other borate-containing product categories in future amendments.

This restriction marks a concrete shift from voluntary substitution to mandatory phase-out for a defined set of borate substances in a high-value industrial application. It underscores that REACH enforcement is increasingly targeting functional performance claims — not just chemical composition — and that compliance timelines are now tightly coupled to formulation development capacity. For affected businesses, it is best understood not as an isolated regulatory update, but as a structural inflection point requiring coordinated technical, regulatory, and commercial response across the corrosion inhibitor value chain.

Source: European Chemicals Agency (ECHA), Official Journal of the European Union (Regulation (EU) 2026/XXXX amending Annex XVII to Regulation (EC) No 1907/2006). Note: Exact OJ publication number and consolidated text remain pending final editorial steps; stakeholders should verify the final version upon publication. Ongoing observation is recommended for national enforcement guidance documents, expected in Q4 2026–Q1 2027.